The Perioperative Pivot: Navigating the New Frontier for Immunotherapy in Early Stage Cancers - Ipsos
  • Ipsos
  • Insights Hub
  • The Perioperative Pivot: Navigating the New Frontier for Immunotherapy in Early Stage Cancers
The Perioperative Pivot: Navigating the New Frontier for Immunotherapy in Early Stage Cancers - Ipsos

The Perioperative Pivot: Navigating the New Frontier for Immunotherapy in Early Stage Cancers

Early-stage immunotherapy: turn the perioperative "black box" into a clear path to ROI.
Cover of the Perioperative Pivout POV from Ipsos

Immune checkpoint inhibitors (PD 1/PD L1) are moving into perioperative (neoadjuvant/adjuvant) care for early-stage solid tumours. This shift is an opportunity - and a strategic black box.

In this Point of View, Ipsos’ experts decode the new perioperative landscape and offer a practical plan for clinical and commercial impact. Grounded in our therapy area experience and a new Ipsos survey of US based medical oncologists, the paper addresses three pressing questions:

  • How to align on a consistent definition of “high-risk” patients across the multidisciplinary care team.
  • How to translate event-free and disease-free survival into clear value stories for stakeholders beyond medical oncology.
  • How to fix handoff gaps between diagnosis, surgery, and systemic treatment so eligible patients stay on pathway.

Read to look ahead and delve into the perioperative pivot for immuno-oncology.
 

Download

The author(s)

More insights about Health

Related news

  • KEYS: Our World in Motion
    E mobility Webinar

    [Webinar] KEYS: Our World in Motion

    At our next KEYS webinar, we’ll be launching the inaugural Ipsos Mobility Report.
  • [Webinar] Real evidence from real experiences: Patient Centric Evidence
    Healthcare Webinar

    [Webinar] Real evidence from real experiences: Patient Centric Evidence

    Regulators, payers and clinicians are asking for more than traditional real world evidence (RWE). They want to understand how treatments affect people’s daily lives - not just what is written in the case report form. But how can you build patient-centric evidence that stands up to scientific, regulatory and commercial scrutiny?
  • Battle For Attention - KEYS Webinar from Ipsos
    Communications Events replay

    [Webinar] KEYS: Battle For Attention

    In today’s hyper-fragmented landscape, communicating using short-form content and social media platforms is an essential part of our toolkit. But are they better suited to short-term engagement rather than long-term brand building? And what does genuinely innovative and creative advertising look like these days?